Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

U.S. Antitrust Lawmakers Express Concern About Insurance Mergers

Diane Bartz  |  September 23, 2015

WASHINGTON (Reuters)—Republican and Democratic lawmakers expressed concern about two multi-billion dollar insurance mergers on Tuesday, using a Senate hearing to take issue with the companies’ arguments that they face expanding competition from new rivals.

Sen. Mike Lee (R-UT), who chairs the Senate Judiciary Committee’s antitrust subcommittee, said he was worried that consumers would be “locked into the offerings of a few dominant companies.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The hearing was called to discuss Anthem Inc’s planned $47 billion takeover of rival Cigna Corp. and Aetna Inc.’s plan to buy rival Humana Inc. for about $37 billion. The deals, announced in July, would reduce the number of nationwide insurers from five to three.

The companies argue that their deals should be uncontroversial because they have little overlap. Overall, Aetna serves 46 million people on the commercial market while Humana has 14 million customers who are mainly served through Medicare Advantage.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Anthem, the largest Blue Cross Blue Shield health plan, has 38 million customers in a diversified network while Cigna insures 14 million people, mostly through large corporate employers.

The CEOs of Aetna, Mark Bertolini, and Anthem, Joseph Swedish, argued that they were facing growing competition from a variety of avenues.

Sen. Richard Blumenthal (D-Conn.) disagreed and noted that earlier mergers had pushed prices up, saying, “These mergers may be the triumph of hope over experience.

“I’m deeply troubled by evidence that shows that neither providers nor consumers benefit (from consolidation),” he said.

Swedish argues that “competition is becoming more robust and not less,” pointing to a two-year old insurance company Oscar, which has 40,000 members.

“What I can share with you is that there are many new players who have entered the market,” he said.

Nationally, premiums paid for employer-sponsored health insurance rose 4% in 2015 and workers are paying sharply higher deductibles, the Kaiser Family Foundation/Health Research & Educational Trust said on Tuesday.

Both Lee and Senator Amy Klobuchar, the top Democrat on the panel, pressed the companies on why they decided not to expand their existing operations but instead opted to buy a rival.

Both said it was cheaper and faster to merge, and that speed mattered. “In that regard, this economic combination makes a lot of sense for us because we can get to market faster,” said Anthem’s Swedish.

Share: 

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:Anthem Inc.Cigna Corp.Health InsuranceHumana Inc.Medical Insurancemerger

Related Articles

    U.S. Court Blocks Anthem-Cigna Deal

    February 9, 2017

    (Reuters)—A federal judge on Wednesday ruled against U.S. health insurer Anthem Inc.’s proposed $54 billion merger with smaller rival Cigna Corp, derailing an unprecedented effort to consolidate the country’s health insurance industry. The U.S. Department of Justice sued in July to stop Anthem’s purchase of Cigna, a deal that would have created the largest U.S….

    U.S. Regulators Sue to Block Anthem-Cigna & Aetna-Humana Mergers

    July 22, 2016

    NEW YORK (Reuters)—U.S. antitrust officials on Thursday moved to block an unprecedented consolidation of the national health insurance market, filing suit against Anthem Inc.’s proposed purchase of Cigna Corp. and Aetna Inc.’s planned acquisition of Humana Inc. The U.S. Department of Justice (DOJ) says the two mergers would reduce competition, raise prices for consumers and…

    CVS Health to Acquire Aetna for $69 billion

    December 4, 2017

    (Reuters)—U.S. drugstore chain operator CVS Health Corp said on Sunday it had agreed to acquire U.S. health insurer Aetna Inc. for $69 billion, seeking to tackle soaring healthcare spending through lower-cost medical services in pharmacies. This year’s largest corporate acquisition will combine one of the nation’s largest pharmacy benefits managers (PBMs) and pharmacy operators with…

    Anthem to Buy Cigna to Create Biggest U.S. Health Insurer

    July 24, 2015

    (Reuters)—Anthem Inc. said on Friday it would buy Cigna Corp. in a deal valued at $54.2 billion, creating the largest U.S. health insurer by membership. The deal—the biggest ever in the health insurance industry—comes three weeks after Aetna Inc agreed to buy Humana Inc for $37 billion and is part of an industry-wide consolidation following…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences